07:00 , May 24, 2010 |  BC Week In Review  |  Clinical News

Amvisc regulatory update

Anika said FDA accepted its corrective actions designed to resolve manufacturing problems raised in a 2008 Warning Letter related to observations made by the agency during a visit of Anika's manufacturing facility in Woburn, Mass....
07:00 , Jun 17, 1996 |  BC Week In Review  |  Company News

Chiron, Lifecore deal

CHIR's Chiron Vision exercised an exclusivity clause in its ophthalmic hyaluronate supply agreement with LCBM. LCBM previously supplied Amvisc and Amvisc Plus Ophthalmic Solution to CHIR under a non-exclusive agreement. LCBM now may not offer...
07:00 , Aug 21, 1995 |  BC Week In Review  |  Clinical News

Chiron, Lifecore regulatory update

LCBM (Chaska, Minn.) received an initial undisclosed purchase order from CHIR's Chiron Vision unit for AMVISC and AMVISC PLUS viscoelastic ophthalmic solutions manufactured from LCBM's sodium hyaluronate. The order calls for European shipments to begin...
08:00 , Mar 13, 1995 |  BioCentury  |  Strategy

Ophthalmics

Chiron as consolidator...
08:00 , Dec 12, 1994 |  BC Week In Review  |  Company News

Lifecore deal

Lifecore Biomedical Inc. (LCBM)   The Chaska, Minn., company finalized its previously announced agreement with Johnson & Johnson 's IOLAB Corp. subsidiary. LCBM will supply sodium hyaluronate powder and pre-filled sterile syringes for IOLAB's Amvisc...
07:00 , Apr 18, 1994 |  BC Week In Review  |  Company News

Lifecore deal

Lifecore Biomedical Inc. (LIFC)   The Chaska, Minn., company signed a letter of understanding with Johnson & Johnson 's Iolab Corp. subsidiary, under which LIFC will supply Iolab with ophthalmic sodium hyaluronate for Iolab's Amvisc...